News & Innovation

A clinical cloud-based deep learning in healthcare

February 23, 2018

A big breakthrough for heart healthcare as FDA approves a new and the first machine learning application for medical imaging


A clinical cloud-based deep learning in healthcare

The FDA’s approval of the first cloud-based machine learning application signals a major stride forward for artificial intelligence (AI) and machine learning in healthcare. The medical imaging platform, developed by Arterys, aims to be used in clinical settings to help physicians understand how a heart is functioning and to provide a precise assessment and diagnosis of the heart with accurate measurements of the volume of blood in each ventricle.

The approval was granted based on the platform’s ability to provide results as accurately as qualified professionals in the field. The key difference lies in the time required for analysis -- Arterys cuts examination time from up to an hour to just 15 seconds per case. “This is a huge deal – it’s the first time this new way of imaging has been cleared for clinical application. It’s about truly helping clinical workflow to move into the cloud and deep learning and do something pretty substantial. It opens the seals, and sets a precedent for what can be done,” said Fabien Beckers, one of the founders of Arterys to Forbes.

The platform, called Arterys Cardio DL, has already learned from 1000 cases and will continue to improve its knowledge as it examines more cases. Its goal is to become able to recognise and identify problems with minimal or no manual interventions.

 

This story was originally published in the Global Health and Travel issue of October 2017

Related Articles

News & Innovation

Laurent Bleu: Giving back to the community in a global pandemic

The COVID-19 pandemic is an ongoing pandemic that has since caused one of the largest global, social and economic disruptions in history. To date, this virus has infected 174 million people and claimed the lives of 3.7 million people. One measure practised worldwide to combat the rising number of COVID-19 cases is mass-testing on the population. The fundamental reason for mass-testing is to ensure that those who are positive are immediately isolated and quarantined to prevent further transmission of the virus.

Read more
News & Innovation

"BDMS" LEADING Healthcare Network in Thailand.

BDMS, leading healthcare network; Bangkok Hospital under BDMS, the No.1 in Newsweek Thailand's hospital ranking.

Read more
News & Innovation

A global call to improve cancer survival

Increased awareness about the benefits of early diagnosis is key to saving lives

Read more

Latest Articles

Health & Wellness

Gynecomastia in Singapore Is Prevailing In Older Men, Especially Those Taking Prescription Medications

Dr Ivan Puah is seeing an increase in older patients in the treatment of gynecomastia in Singapore. Men above 40 years old who are on prescription medications are more susceptible to experiencing enlarged male breasts. Statin, amoxicillin, and proton pump inhibitors have proven to increase gynecomastia risk.

Read more
Health & Wellness

Gynecomastia in Singapore Is Prevailing In Older Men, Especially Those Taking Prescription Medications

Dr Ivan Puah is seeing an increase in older patients in the treatment of gynecomastia in Singapore. Men above 40 years old who are on prescription medications are more susceptible to experiencing enlarged male breasts. Statin, amoxicillin, and proton pump inhibitors have proven to increase gynecomastia risk.

Read more
Medical Care

Innovative scoliosis surgery presents a conundrum for patients

Vertebral body tethering could become the new gold standard treatment for curved spine if we figure out the right candidates

Read more
Terms & Conditions Privacy Policy
Copyright © 2015 - 2020. All rights reserved.